Jingye Zhou, Eccogene CEONovember 9, 2023 03:54 AM ESTUpdated 06:32 AM DealsR&DAstraZeneca puts down $185M upfront for PhI oral GLP-1 as it shoots for next-gen winAmber TongSenior EditorAstraZeneca has recruited a new star to its budding GLP-1 show, picking up an early-stage oral candidate from China’s Eccogene in a deal featuring $185 million upfront. While...
Tag: <span>oral drug</span>
Post
Oral Drug for Brain Tumor Could Change Treatment Landscape
Neil Osterweil June 04, 2023 UPDATED June 9, 2023 // Editor’s note: This story has been updated with additional comments from Dr Rimas Vincas Lukas of Northwestern University. CHICAGO — Patients with a certain type of brain tumor could soon be treated with an oral targeted drug instead of undergoing more toxic chemotherapy and radiation, say researchers reporting new results...
Post
Oral Drug for Brain Tumor Could Change Treatment Landscape
Neil Osterweil June 04, 2023 CHICAGO — Patients with a certain type of brain tumor could soon be treated with an oral targeted drug instead of undergoing more toxic chemotherapy and radiation, say researchers reporting new results that could potentially change the treatment landscape. The investigational drug vorasidenib (Servier) is awaiting approval for use in gliomas bearing...
Post
Phase 3 clinical trial results lead to approval of oral drug for red blood cell disorder
by Massachusetts General Hospital Credit: CC0 Public Domain Researchers have published the results of a clinical trial that led the U.S. Food and Drug Administration to recently approve mitapivat for the treatment of adults with pyruvate kinase deficiency—a rare genetic condition that leads to the destruction of red blood cells, or hemolytic anemia. The primary...
Post
Trials reveal efficacy and safety of oral drug for treating anemia associated with kidney disease
by American Society of Nephrology Credit: Unsplash/CC0 Public Domain Pooled results from recent clinical trials indicate that an oral drug called roxadustat is an effective treatment for anemia in patients with chronic kidney disease. The results are published in an upcoming issue of CJASN. Many individuals with kidney dysfunction develop anemia or a shortage of healthy red blood cells...